Eisai
4523.T
#2184
Rank
โ‚น761.74 B
Marketcap
โ‚น2,700
Share price
0.11%
Change (1 day)
9.03%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Revenue for Eisai (4523.T)

Revenue in 2023: โ‚น440.55 Billion

According to Eisai's latest financial reports the company's current revenue (TTM ) is โ‚น456.03 Billion. In 2023 the company made a revenue of โ‚น440.55 Billion a decrease over the revenue in the year 2022 that were of โ‚น460.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eisai from 2009 to 2023

Annual revenue

Year Revenue Change
2023โ‚น440.55 B-4.29%
2022โ‚น460.29 B-2.66%
2021โ‚น472.87 B-3.16%
2020โ‚น488.30 B12.95%
2019โ‚น432.33 B8.61%
2018โ‚น398.07 B22.8%
2017โ‚น324.16 B-2.86%
2016โ‚น333.69 B6.97%
2015โ‚น311.94 B-5.29%
2014โ‚น329.36 B-10.05%
2013โ‚น366.15 B-5.13%
2012โ‚น385.93 B-12.23%
2011โ‚น439.71 B4.26%
2010โ‚น421.74 B8.7%
2009โ‚น387.97 B